## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-06-20T17:02:30.896Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "OneBlood Donor App"
developer_entity: "OneBlood"
bundle_id: "com.hematerra.oneblood"
app_store_id: "1253115377"
category: "Health & Fitness"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2025-12-29"
report_date: "2026-06-20"
last_verified: "2026-06-20"
report_version: "2.4.01"
total_reviews: 359
overall_rating: 2.27
sentiment: "Frustrated"
sentiment_score: 25
confidence: "high"
confidence_score: 0.5
top_complaint_theme: "Technical instability and booking friction"
review_sample_size: 99
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 3
nemesis: "MySejahtera"
competitor_count: 11
tags: ["health & fitness", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "existing", "prospective", "blood"]
canonical_url: "https://marlvel.ai/apps/oneblood-donor-app"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# OneBlood Donor App App Audit

## TL;DR {#tldr}

- **Category**: Health & Fitness · Free
- **Signal**: Rating 2.27 · Sentiment Frustrated
- **Recent focus**: Technical instability and booking friction (top complaint)

> **TL;DR:** OneBlood Donor App is a health & fitness app by OneBlood, rated 2.27/5 by 359 users, with Frustrated user sentiment (25/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** OneBlood Donor App faces Frustrated user sentiment (2.27/5 from 359 reviews), with technical instability and booking friction as the primary user concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 2.27/5 (359 reviews) |
| **User Mood** | Frustrated |
| **Category** | Health & Fitness |
| **Developer** | OneBlood |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | High (0.5/1.0) |
| **Data Age** | 12d |

## Metadata & Market Performance
- **Publisher:** OneBlood
- **Category:** Health & Fitness
- **Target Audience:** Existing and prospective blood donors managing donation schedules and personal health metrics.
- **Platforms:** iOS & Android
- **Version Audited:** 2.4.01
- **Audit Date:** 2026-06-20
- **Signal Count:** 99 reviews analyzed
- **Confidence:** High (0.5/1.0)
- **App Store ID (iOS):** 1253115377
- **Bundle ID:** com.hematerra.oneblood
- **Google Play ID:** com.hematerra.oneblood
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-06-20

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** OneBlood Donor App is a health utility for scheduling blood donations and accessing screening history on iOS and Android.
**Why users hire it:** Donors hire this app to manage their donation cadence and review personal health metrics, but the current technical friction forces users to seek alternatives for reliable health tracking.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Appointment Scheduling:** Direct booking interface for blood donation slots.
- **[Differentiator] Health Screening History:** Access to personal health metrics like cholesterol and blood pressure.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

OneBlood maintains a niche utility position in the Health & Fitness category, but its 2.18 average rating across 359 total ratings indicates a failure to retain users compared to broader health platforms.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access for all users
- **Analysis:** The app functions as a non-monetized utility for donor management.

<!-- section:sentiment -->
## 🔴 User Sentiment (High Confidence: 359 reviews) {#user-sentiment}
- **Overall Rating:** 2.27/5
- **Platform Split:** iOS 1.9/5 (116 ratings) | Android 2.4/5 (243 ratings)
- **Overall Sentiment:** Frustrated

### Top Complaints (Impact Areas)
- **Technical instability and booking friction**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Direct integration with blood center scheduling [standard utility]

**Critical Frictions:**
- 1.93 iOS rating [platform metric]
- Technical instability in booking flows [user complaint theme]

**Growth Levers:**
- Native Apple Health integration [competitor gap]

**Market Threats:**
- MySejahtera government-backed health record scale [nemesis threat]

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The competitive landscape has expanded to include government-backed health platforms, and the app's positioning has shifted to reflect declining iOS performance and a pivot toward booking stability.

**Overall trend**: Declining
**Compared at**: 2026-06-20

### High-impact changes
- **[Shifted] Competitive Nemesis Shift** (positioning) — The primary nemesis changed from Vitalant to MySejahtera, reflecting a shift from niche blood donation competition to government-backed health ecosystem threats.
- **[Declined] iOS Rating Decline** (sentiment) — The reported iOS rating dropped from 2.18 to 1.93, indicating a worsening user experience on the platform.

### Medium-impact changes
- **[Added] New Strategic Opportunity** (swot) — Native Apple Health integration was identified as a new opportunity to address current feature gaps.
- **[Shifted] PM Action Pivot** (positioning) — The decision for the primary action item changed from 'Invest' to 'Pivot', signaling a more urgent focus on booking flow stability.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### OneBlood Donor App vs MySejahtera — Head to Head
- **[MySejahtera](https://marlvel.ai/apps/my-gov-onegovappstore-mysejahtera)** by JABATAN DIGITAL NEGARA (JDN): MySejahtera serves as a massive, government-backed digital health ecosystem that overlaps with OneBlood’s goal of managing personal health records and donation-related medical history.
  - **Key differences:**
    - Massive government-mandated user base creates an insurmountable network effect for health record management.
    - Integrated vaccination and national healthcare services provide utility far beyond simple blood donation tracking.
    - High-frequency updates and massive scale ensure it remains the primary health portal for millions.
  - **Where OneBlood Donor App wins:**
    - ✅ Specialized focus on blood donation logistics provides a more streamlined experience for donors.
    - ✅ Direct integration with blood center scheduling reduces friction for specific donation-related tasks.
  - **Where MySejahtera wins:**
    - ❌ Unmatched scale and government backing ensure long-term data reliability and user trust.
    - ❌ Broad feature set covering vaccination and general health records keeps users engaged daily.
  - **Verdict:** OneBlood cannot compete on scale; it must double down on the niche donor experience and community-building features that a generic government app lacks.

### Contenders (Strong Challengers)
- **[MediWear: Medical ID for Watch](https://marlvel.ai/apps/app-footware-mediwear)** by Adam Foot: MediWear competes for the user's health data real estate by providing critical medical information directly on wearable devices.
  - Watch-first UX allows for instant access to medical IDs, a critical gap in OneBlood's mobile-only strategy.
  - Offline accessibility ensures critical health data is available even when the user lacks cellular connectivity.
- **[CPH CARE](https://marlvel.ai/apps/com-cph-cphmobileapp)** by Nextgen Innovation Ltd.: CPH CARE targets the same health-conscious demographic by offering direct doctor booking and prescription management services.
  - Direct medicine ordering and prescription management creates a transactional loop that drives daily app usage.
  - Emergency contact services provide immediate safety value that differentiates it from OneBlood's donation-only focus.
- **[AlayaCare](https://marlvel.ai/apps/alayacare)** by AlayaCare Inc.: AlayaCare competes in the professional health management space, overlapping with OneBlood's clinical documentation and health screening features.
  - Advanced AI assistant (Layla) provides proactive care support that exceeds OneBlood's static history view.
  - GPS-based visit verification offers a level of operational utility that OneBlood’s donor app lacks.
- **[AI Body Temperature Analyser](https://marlvel.ai/apps/com-mosin-thermometer)** by Sergey Mosin: This app competes for the health-conscious user's attention by offering granular symptom tracking and statistical health analysis.
  - Provides automated statistical analysis of health trends that OneBlood currently lacks for its users.
  - Focuses on daily symptom monitoring which encourages higher app retention than periodic blood donations.

### Peers (What They Do Better)
- **[EMRA Antibiotic Guide](https://marlvel.ai/apps/com-emra-antibioticguide)** by Emergency Medicine Residents' Association: This app provides specialized medical reference tools, competing for the attention of users seeking specific health data.
  - Specialized dosage calculators provide immediate, high-utility value for users managing specific health conditions.
  - Predictive search functionality allows for faster information retrieval than OneBlood’s current history-based navigation.
- **[Hyperice](https://marlvel.ai/apps/hyperice)** by Hyper Ice, Inc: Hyperice competes for the active, health-conscious user by focusing on recovery routines and device-integrated health management.
  - Bluetooth device control creates a hardware-software ecosystem that locks users into their recovery platform.
  - Guided recovery routines provide active, daily value compared to OneBlood's passive donation history tracking.
- **[AHA ACLS](https://marlvel.ai/apps/org-healthcaretransformationlab-acls-release)** by Massachusetts General Hospital: AHA ACLS competes in the clinical health space by providing protocol-driven tools for medical professionals and informed patients.
  - AHA-vetted content provides a gold-standard reference that builds immense trust with medical-minded users.
  - Clinical timers and logging tools offer professional-grade utility that exceeds OneBlood's basic health screening.
- **[Merck Manual Consumer](https://marlvel.ai/apps/merck-manual-consumer)** by Merck & Co Inc: This app serves as a high-authority medical reference library, competing for the user's time spent on health education.
  - Deep, peer-reviewed medical content establishes a level of authority OneBlood cannot match in health education.
  - Interactive health quizzes drive engagement through gamified learning rather than just static record viewing.

### New Kids on the Block (What's Innovative)
- **[Corpusmetra](https://marlvel.ai/apps/corpusmetra)** by Marko Zamurovic: This newcomer focuses on hardware integration and Apple Health syncing, targeting the data-driven health enthusiast.
  - Privacy-first architecture and native Apple Health integration appeal to users wary of large health platforms.
- **[Symtraq - Symptom Tracker](https://marlvel.ai/apps/symtraq-symptom-tracker)** by Softpulse Infotech: A new entrant focusing on holistic symptom and mood tracking, competing for the user's daily health logging habits.
  - Integrated mood and medication tracking offers a more comprehensive daily health journal than OneBlood.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v2.4.02, 5 months ago):** Technical maintenance release focusing on performance, memory optimization, security updates, and UI/UX refinements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- No major feature releases identified.
- Maintenance-mode status limits user growth.

> **Cadence:** 2 total versions · 0 majors in last 6 months · 173 days since last update · 77 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

OneBlood Donor App is a challenged health & fitness app that is completely free.
With a 2.27/5 rating from 359 reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** OneBlood fails to provide a stable donor experience, because technical friction in the booking flow erodes user trust, so the PM must prioritize stability over new feature development to prevent donor churn.
<!-- speakable-end -->

**Best for:** Existing and prospective blood donors managing donation schedules and personal health metrics.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Rebuild appointment booking flow because booking friction is the primary churn driver → increase successful donation rate — *User reviews consistently flag booking failures as the top frustration theme.* _(trade-off: deprioritize Pause all non-critical UI updates — booking stability is the primary retention lever.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Native Apple Health integration (available in Corpusmetra but absent here)
- Wearable-first UX (available in MediWear but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The health utility market is consolidating around platforms that offer seamless data integration, leaving OneBlood exposed due to its static, maintenance-mode posture. Continued technical friction will likely drive donors to seek alternative health-management apps for their screening data, reducing the app's role to a simple, low-engagement booking tool.

- 🔴 Persistent technical instability in the latest release erodes user trust, which compounds the rating drag already visible on iOS.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 2.27/5 |
| Total Reviews | 359 |
| Sentiment | Frustrated (25/100) |
| Confidence | High |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 2 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **OneBlood Donor App** (this app) | 2.27/5 | Frustrated | OneBlood |
| [AHA ACLS](https://marlvel.ai/apps/org-healthcaretransformationlab-acls-release) | 4.9/5 | Frustrated | Massachusetts General Hospital |
| [CPH CARE](https://marlvel.ai/apps/com-cph-cphmobileapp) | 4.1/5 | N/A | Nextgen Innovation Ltd. |
| [AI Body Temperature Analyser](https://marlvel.ai/apps/com-mosin-thermometer) | 3.9/5 | N/A | Sergey Mosin |
| [EMRA Antibiotic Guide](https://marlvel.ai/apps/com-emra-antibioticguide) | 3.3/5 | Upset | Emergency Medicine Residents' Association |
| [MySejahtera](https://marlvel.ai/apps/my-gov-onegovappstore-mysejahtera) | 4.1/5 | Frustrated | JABATAN DIGITAL NEGARA (JDN) |

## Company Profile
- **Developer:** OneBlood

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/oneblood-donor-app/id1253115377?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.hematerra.oneblood&hl=en&gl=us)
- **Sources:** App store metadata, User reviews.

## Related Intel Reports
- [*AHA ACLS*](https://marlvel.ai/apps/org-healthcaretransformationlab-acls-release) (Massachusetts General Hospital) — 4.9/5 Rating | Negative Sentiment
- [*CPH CARE*](https://marlvel.ai/apps/com-cph-cphmobileapp) (Nextgen Innovation Ltd.) — 4.1/5 Rating | N/A Sentiment
- [*AI Body Temperature Analyser*](https://marlvel.ai/apps/com-mosin-thermometer) (Sergey Mosin) — 3.9/5 Rating | N/A Sentiment
- [*EMRA Antibiotic Guide*](https://marlvel.ai/apps/com-emra-antibioticguide) (Emergency Medicine Residents' Association) — 3.3/5 Rating | Terrible Sentiment
- [*MySejahtera*](https://marlvel.ai/apps/my-gov-onegovappstore-mysejahtera) (JABATAN DIGITAL NEGARA (JDN)) — 4.1/5 Rating | Negative Sentiment
- [*Corpusmetra*](https://marlvel.ai/apps/corpusmetra) (Marko Zamurovic) — N/A Rating | N/A Sentiment
- [*Symtraq - Symptom Tracker*](https://marlvel.ai/apps/symtraq-symptom-tracker) (Softpulse Infotech) — N/A Rating | N/A Sentiment
- [*Merck Manual Consumer*](https://marlvel.ai/apps/merck-manual-consumer) (Merck & Co Inc) — 4.6/5 Rating | Positive Sentiment
- [*AlayaCare*](https://marlvel.ai/apps/alayacare) (AlayaCare Inc.) — 4.2/5 Rating | Positive Sentiment
- [*Hyperice*](https://marlvel.ai/apps/hyperice) (Hyper Ice, Inc) — 4.0/5 Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 99
- **Data Sources:** user reviews, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 12 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/oneblood-donor-app)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.